Related Experiment Video
Updated: May 4, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Management of peripherally inserted central catheters (PICC) in pediatric heart failure patients receiving continuous
Maeve Giangregorio1, Sandra Mott1, Elizabeth Tong1
1Boston Children's Hospital, Boston, MA.
Insights
Low-dose heparin may improve peripherally inserted central catheter (PICC) line patency in pediatric heart failure patients on continuous inotropes. Findings suggest heparin use is clinically significant, supporting current practices for maintaining PICC line function.
Area of Science:
- Pediatric Cardiology
- Vascular Access Management
- Pharmacology
Background:
- Peripherally inserted central catheters (PICCs) are crucial for administering continuous inotropes in pediatric heart failure.
- Maintaining PICC line patency is essential to avoid complications and ensure effective treatment.
- Current practices for maintaining patency, particularly regarding anticoagulation, require evaluation.
Purpose of the Study:
- To evaluate the practice of maintaining PICC line patency in pediatric heart failure patients receiving continuous inotropes.
- To compare the duration of PICC line patency and the need for thrombolytic agents between patients receiving low-dose continuous heparin and those receiving no heparin.
Main Methods:
- A case-control retrospective chart review was conducted.
- Two cohorts were compared: one receiving low-dose continuous heparin and one receiving no heparin.
- Outcomes assessed included duration of PICC line patency (in days) and the requirement for thrombolytic agents.
Main Results:
- The median duration of PICC line patency was 24 days for the heparin group versus 16 days for the no heparin group (p=0.07).
- Thrombolytic agent use was 28% in the heparin group compared to 50% in the no heparin group (p=0.08).
- While not statistically significant, the observed differences suggest a clinically significant benefit of heparin.
Conclusions:
- Low-dose continuous heparin may be beneficial in maintaining PICC line patency in pediatric heart failure patients on inotropes.
- Findings support the clinical significance of current practices involving heparin for PICC line maintenance.
- Further prospective studies may be warranted to confirm these findings and establish optimal anticoagulation protocols.
Abstract:
The study aim was to evaluate present practice of maintaining PICC line patency in pediatric heart failure patients receiving continuous inotropes by comparing one cohort receiving low dose continuous heparin with one receiving no heparin. A case control retrospective chart review compared the two cohorts on duration of patency (measured in days) and need for thrombolytic agents. Median duration of patency for the heparin group was 24 days versus 16 days for the no heparin group (p=0.07). Use of thrombolytic agents was 28% in the heparin group compared to 50% in the no heparin group (p=0.08). Although not statistically significant, findings were clinically significant and supportive of current practice.
Related Concept Videos
Endocarditis IV: Nursing Management
Parentral Nutrition: Centeral and Peripheral Parental Nutrition
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
Pericarditis IV: Nursing Management
Cardiac Catheterization IV: Nursing Management
Continuous Renal Replacement Therapy
Heart Failure VI: Adjunct Therapies

